Cadrenal Therapeutics, Inc. Payments for Purchase of Other Assets
Cadrenal Therapeutics, Inc. (CVKD) had Payments for Purchase of Other Assets of $50.00 thousand as of 2025-09-12, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForPurchaseOfOtherAssets1 · last filed 2026-05-07
- 2025-09-12: Payments for Purchase of Other Assets $50.00K.
- 2022-06-01: Payments for Purchase of Other Assets $100.00K.
| Period end | Payments for Purchase of Other Assets |
|---|---|
| 2025-09-12 | $50.00K 10-Q · filed 2026-05-07 |
| 2022-06-01 | $100.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |